← Eichor
Condition: Relapsing Polychondritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Relapsing Polychondritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06873100Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT02257866An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06941376Longitudinal Study for Relapsing Polychondritis
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04919538
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.